Accès ouvert
2025
article
OpenAlex
Jun Wang, Godwin Imade, Sulaimon Akanmu, Jonah Musa et autres
OBJECTIVES: Cervical cancer is one of the most frequently diagnosed cancers and a leading cause of cancer-related deaths in women in low- and middle-income countries (LMICs), accounting for nearly 85% of the global cervical cancer burden. High-risk human papillomavirus (hrHPV) infection is …
us, Nigéria
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Jun Wang, Godwin Imade, Sulaimon Akanmu, Jonah Musa et autres
BACKGROUND: Easy-to-use, rapid, scalable, high-throughput, and cost-effective HPV tests are urgently needed for low-resource settings. Atila Biosystems' high-throughput, cost-effective, and clinically validated ScreenFire HPV Risk Stratification (RS) assay identifies 13 high risk HPV (hrHPV) in 4 groups based on their oncogenic risk …
us, Nigéria, co
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Paul L. Reiter, Abigail B. Shoben, Sarah Cooper, Amie M. Ashcraft et autres
BACKGROUND: Despite the promise of mail-based human papillomavirus (HPV) self-collection programs for increasing cervical cancer screening, few have been evaluated in the United States. We report the results of a mail-based HPV self-collection program for underscreened women living in Appalachia. METHODS: We …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Jerome L. Belinson, Jack Cuzick, Paul Castle, Mark Schiffman et autres
Given that high-risk human papillomavirus (HPV) is the necessary cause of virtually all cervical cancer, the clinical meaning of HPV-negative cervical precancer is unknown. We, therefore, conducted a literature search in Ovid MEDLINE, PubMed Central, and Google Scholar to identify English-language studies …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Robert G. Pretorius, Jerome L. Belinson, Marc Esser, Frank J. Taddeo et autres
To optimize HPV vaccination implementation at the population-level in China, data are needed on age-specific HPV 16, 18, 6 and 11 prevalence. This cross-sectional, population-based study evaluated the age- and type-specific HPV 16, 18, 6 and 11 prevalence of DNA and serum …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Jun Hou, Jerome L. Belinson, Hui Du, Changzhong Li et autres
OBJECTIVES: The human papillomavirus (HPV) screening assays from Atila Biosystems, including the new AmpFire (14 type) and ScreenFire RS (13 type), were subjected to a series of validation tests. METHODS: We used a set of samples from the Chinese Multi-Site Screening Trial …
cn, hk, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Hui Du, Xinfeng Qu, Guixiang Wang, Chunlei Guo et autres
OBJECTIVE: To evaluate the feasibility of an internet-facilitated community model for cervical cancer screening using self-collected HPV testing as primary screening. METHOD: A population-based cervical cancer screening program was conducted in the suburb of Shenzhen, China, from September 2014 to July 2017. …
cn, us, hk
(code pays fourni par la source)
2023
article
OpenAlex
Chad M. Michener, Stephanie Ricci, Mariam AlHilli, Lindsey Beffa et autres
us, gb
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Jerome L. Belinson, Robert G. Pretorius, Ruifang Wu, You‐Lin Qiao
Abstract Since 1998, Preventive Oncology International, Inc. (POI) has been at the forefront of studying human papillomavirus (HPV) self-collection for cervical cancer screening, with a significant focus in China. Through multiple clinical trials over the past 25 years, POI has explored various …
us, cn
(code pays fourni par la source)
Accès ouvert
2023
supplementary-materials
OpenAlex
Philip E. Castle, Amanda J. Pierz, Rachael Adcock, Shagufta Aslam et autres
Supplemental Figures 1-2
Accès ouvert
2023
supplementary-materials
OpenAlex
Philip E. Castle, Amanda J. Pierz, Rachael Adcock, Shagufta Aslam et autres
Supplementary Data Legends
Accès ouvert
2023
other
OpenAlex
Philip E. Castle, Amanda J. Pierz, Rachael Adcock, Shagufta Aslam et autres
Abstract Given that high-risk human papillomavirus (HPV) is the necessary cause of virtually all cervical cancer, the clinical meaning of HPV-negative cervical precancer is unknown. We, therefore, conducted a literature search in Ovid MEDLINE, PubMed Central, and Google Scholar to identify English-language …